Mingqing Wang

发表

Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR‐&ggr;, AMPK/Akt/mTOR signaling and autophagy

Lu Lu, Lianbo Wei, Wangqiu Gong, 2017, International immunopharmacology.